NAPWA

The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. HIV, all of which are now available in Australia. read more »

A New Zealand company is working on an antiviralA medication or substance which is active against one or more virusesA small infective organism which is incapable of reproducing outside a host cell.. May include anti-HIV drugs, but these are more accurately termed antiretroviralsA medication or other substance which is active against retroviruses such as HIV.. agent that utilises the immune system to fight fluA highly contagious and relatively common viral infection of the respiratory system, transmitted by infected droplets of moisture which may be spread through coughing and sneezing. Most people with flu recover but some go on to develop secondary infections such as pneumoniaAn inflammation of the lung, usually caused by infection with bacteria or other microorganisms, in which the air sacs of the lung become filled with inflammatory cells which solidify and inhibit breathing. which may be fatal., hepatitis and HIV. read more »

A warning has been issued by Tibotec, the manufacturers of Prezista (darunavir) regarding the risk of developing drug- induced hepatitis while taking the treatment. read more »

Even among long-term survivors, Steven has survived more than most. Steven has been near death a number of times, and has always found the strength to pull through. Despite numerous obstacles, Steven has always been able to find the strength to work out ways to make the best of his situation and develop new strategies to manage his health. read more »

NAPWHA’s Treataware Project, a phone line, clinical trials website and booklet giving advice on treatments and living well with HIV, was launched by Dr Jonathan Anderson, President of ASHMAustralasian Society for HIV Medicine. The peak Australasian organisation representing the medical and health sector in HIV/AIDS and related areas. on May 19 in Sydney. read more »

Continuing improvements in HIV treatment are helping many people with HIV lead healthy lives, but some HIV-positive people may not be well-enough informed about the latest treatment options, the National Association of People Living with HIV/AIDS (NAPWHA) has said in a statement to mark the launch of an innovative new HIV treatments information project. read more »

Treataware, a suite of major NAPWHA/ATPA treatments intitatives, will be launched in May 2008.  read more »

John Daye, NAPWHA's Health, Treatments & Research Portfolio Co-Convenor reports from the 15th Conference on Retroviruses and Opportunistic Infections (CROI) held in Boston, USA from 3-6 February 2008 read more »

This booklet is for people with HIV who experience side effects from HIV treatments or other physical symptoms that may be due to HIV infection. It will help you identify side effects, and provides suggestions on how to prevent, manage, reduce or eliminate some common side effects. read more »

A Peru based study found that daily treatment with the anti-herpes drug valaciclovir significantly reduced HIV viral loadA measurement of the quantity of HIV RNA in the blood. Viral load blood test results are expressed as the number of copies (of HIV) per milliliter of blood plasma. in both the blood and genital secretions of HIV/herpes simplex virusA small infective organism which is incapable of reproducing outside a host cell.-2- infected men who have sex with men (MSM). read more »